Mark Speakman

4.0k total citations · 2 hit papers
86 papers, 2.7k citations indexed

About

Mark Speakman is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Speakman has authored 86 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Urology, 43 papers in Rheumatology and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Speakman's work include Urinary Bladder and Prostate Research (58 papers), Pelvic floor disorders treatments (36 papers) and Prostate Cancer Diagnosis and Treatment (34 papers). Mark Speakman is often cited by papers focused on Urinary Bladder and Prostate Research (58 papers), Pelvic floor disorders treatments (36 papers) and Prostate Cancer Diagnosis and Treatment (34 papers). Mark Speakman collaborates with scholars based in United Kingdom, Germany and Italy. Mark Speakman's co-authors include Francesco Montorsi, Roger Kirby, Stephan Madersbacher, Peter Gilling, Christian Gratzke, Rainer M. Kuntz, Sascha Ahyai, Steven A. Kaplan, Christian G. Stief and Christos V. Ioannou and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ and The Journal of Urology.

In The Last Decade

Mark Speakman

80 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement

2010 459 citations Stephan Madersbacher, Mark Speakman et al. European Urology profile →
Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms

2023 87 citations Stavros Gravas, Mauro Gacci et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Speakman United Kingdom	26	2.3k	1.6k	1.4k	396	291	86	2.7k
B. Lukacs France	21	2.1k 0.9×	1.1k 0.7×	1.1k 0.8×	770 1.9×	189 0.6×	74	2.4k
Clair Haakenson United States	8	714 0.3×	626 0.4×	299 0.2×	462 1.2×	110 0.4×	14	2.9k
Libby Black United States	19	338 0.1×	586 0.4×	182 0.1×	140 0.4×	85 0.3×	52	1.2k
Katrine L. Wallace United States	13	127 0.1×	224 0.1×	275 0.2×	259 0.7×	76 0.3×	29	1.2k
Rudolf P. Obermayr Austria	11	305 0.1×	103 0.1×	176 0.1×	445 1.1×	171 0.6×	16	1.3k
T Talseth Norway	19	352 0.2×	101 0.1×	680 0.5×	52 0.1×	209 0.7×	57	1.4k
Larry Radican United States	24	145 0.1×	62 0.0×	132 0.1×	1.1k 2.7×	244 0.8×	59	1.9k
Nikolaos Ioakeimidis Greece	14	125 0.1×	116 0.1×	72 0.1×	359 0.9×	54 0.2×	34	1.2k
Stephen P. Motsko United States	11	154 0.1×	71 0.0×	154 0.1×	58 0.1×	101 0.3×	23	637
Kristen Migliaccio–Walle United States	16	86 0.0×	117 0.1×	82 0.1×	43 0.1×	153 0.5×	48	856

Countries citing papers authored by Mark Speakman

Since Specialization

Citations

This map shows the geographic impact of Mark Speakman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Speakman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Speakman more than expected).

Fields of papers citing papers by Mark Speakman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Speakman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Speakman. The network helps show where Mark Speakman may publish in the future.

Co-authorship network of co-authors of Mark Speakman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Speakman. A scholar is included among the top collaborators of Mark Speakman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Speakman. Mark Speakman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gravas, Stavros, Mauro Gacci, Christian Gratzke, et al.. (2023). Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms. European Urology. 84(2). 207–222. 87 indexed citations breakdown →

Abt, Dominik, Hans‐Peter Schmid, & Mark Speakman. (2021). Reasons to consider prostatic artery embolization. World Journal of Urology. 39(7). 2301–2306. 9 indexed citations

Karavitakis, Markos, Iason Kyriazis, Muhammad Imran Omar, et al.. (2019). Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis. European Urology. 75(5). 788–798. 43 indexed citations

Speakman, Mark, Jean‐Nicolas Cornu, Mauro Gacci, et al.. (2019). What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?. European Urology Focus. 5(3). 351–356. 29 indexed citations

Nickel, J. Curtis & Mark Speakman. (2019). Post-Void Dribbling—Is it Time to Take Another Look at a Common Urology Problem?. The Journal of Urology. 201(6). 1064–1066. 3 indexed citations

Wade, Julia, Peter Holding, Leila Rooshenas, et al.. (2015). Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial. BMJ Open. 5(9). e008953–e008953. 24 indexed citations

Kirby, Michael, Christopher R. Chapple, Graham Jackson, et al.. (2013). Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co‐diagnosis. International Journal of Clinical Practice. 67(7). 606–618. 53 indexed citations

Speakman, Mark, et al.. (2011). UP-02.138 The Prostate Cancer Gene 3 (PCA3) Urine Test: Improving Prediction of Initial Biopsy and Management. Urology. 78(3). S307–S308. 1 indexed citations

Drake, Marcus J., Mark Speakman, P. Van Kerrebroeck, Ted Drogendijk, & Monique Klaver. (2011). MP-05.01 Evaluating the Efficacy and Safety of Fixed-Dose Combinations of Tamsulosin OCAS™ and Solifenacin in Male LUTS with Storage and Voiding Symptoms: An Overview of the NEPTUNE Trial. Urology. 78(3). S58–S58. 2 indexed citations

10.

Nickel, J. Curtis & Mark Speakman. (2011). SHOULD WE REALLY CONSIDER GLEASON 6 PROSTATE CANCER?. British Journal of Urology. 109(5). 645–646. 28 indexed citations

11.

Speakman, Mark, et al.. (2007). Campbell‐Walsh Urology 9 ^th Edition, e‐edition. British Journal of Urology. 100(2). 453–454. 1 indexed citations

12.

Speakman, Mark, et al.. (2007). Acute urinary retention: medical management and the identification of risk factors for prevention. Nature Clinical Practice Urology. 4(8). 422–431. 6 indexed citations

13.

Dorey, Grace, et al.. (2005). Pelvic floor exercises for erectile dysfunction. British Journal of Urology. 96(4). 595–597. 48 indexed citations

14.

Perimenis, Petros, et al.. (2003). Carcinosarcoma of the ureter: A rare, pleomorphic, aggressive malignancy. International Urology and Nephrology. 35(4). 491–493. 11 indexed citations

15.

Speakman, Mark. (2001). Initial Choices and Final Outcomes in Lower Urinary Tract Symptoms. European Urology. 40(Suppl. 4). 21–30. 18 indexed citations

16.

Speakman, Mark. (2001). Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: What Is the Available Evidence for Rational Management?. European Urology. 39(Suppl. 3). 6–12. 14 indexed citations

17.

Reijke, T.M. De, et al.. (1999). Tamsulosin 0.4 mg Once Daily: Effect on Sexual Function in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction. European Urology. 36(4). 335–341. 118 indexed citations

18.

Speakman, Mark. (1999). Who Should Be Treated and How? Evidence-Based Medicine in Symptomatic BPH. European Urology. 36(Suppl. 3). 40–51. 37 indexed citations

19.

Bates, T. S., et al.. (1997). A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. British Journal of Urology. 79(6). 927–932. 42 indexed citations

20.

Melekos, Michael D., et al.. (1994). Evaluation of Urodynamic Parameters following Burch Colposuspension. Urologia Internationalis. 53(3). 150–154. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact